![Romeo Mirzac](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Mr. Romeo Mirzac is Chief Accounting Officer at Proteostasis Therapeutics, Inc.
He received his undergraduate degree from the Bucharest Academy of Economic Studies and a graduate degree from the University of New Hampshire.
Eerdere bekende functies van Romeo Mirzac
Bedrijven | Functie | Einde |
---|---|---|
PROTEOSTASIS THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 18-03-2016 |
Opleiding van Romeo Mirzac
University of New Hampshire | Graduate Degree |
Bucharest Academy of Economic Studies | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Proteostasis Therapeutics, Inc.
![]() Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |